{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:20:54Z","timestamp":1783405254481,"version":"3.54.6"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gout is a systemic inflammatory disorder increasingly associated with cardiovascular comorbidities. However, its potential relationship with atrial fibrillation (AF), especially in young adults, has not been fully delineated. To investigate the association between gout and incident AF in a large nationwide cohort of Korean adults aged 20\u201339 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed 6,506,721 individuals from the Korean National Health Insurance Service (NHIS) database. Gout and AF were identified using ICD-10 codes M10 and I48, respectively. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident AF after adjusting for demographic, lifestyle, and clinical factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During a median follow-up of 12.59 years, gout was associated with a significantly increased risk of AF (fully adjusted HR, 1.44; 95% CI, 1.31\u20131.58). The cumulative incidence of AF was significantly higher in the gout group (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u2009.001). Subgroup analyses demonstrated stronger associations among non-obese individuals and those with chronic kidney disease (CKD).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Gout was associated with an increased risk of atrial fibrillation among young adults. These findings suggest that gout may serve as a clinically relevant risk marker for AF, underscoring the need for proactive cardiovascular risk assessment in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1862887","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:46:51Z","timestamp":1783403211000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased risk of atrial fibrillation in young adults with gout: a nationwide cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Eunsong","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Korea University Ansan Hospital","place":["Ansan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics, Soongsil University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwan Gyu","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Korea University Guro Hospital","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyun","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Korea University Ansan Hospital","place":["Ansan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Korea University Anam Hospital","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11926-015-0495-2","article-title":"Hyperuricemia, gout, and cardiovascular disease: an update","volume":"17","author":"Abeles","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/gucdd1030014","article-title":"Gout and cardiovascular disease: mechanisms, risk estimations, and the impact of therapies","volume":"1","author":"Andr\u00e9s","year":"2023","journal-title":"Gout Urate Cryst Depos Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00296-021-04876-6","article-title":"The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis","volume":"41","author":"Cox","year":"2021","journal-title":"Rheumatol Int"},{"key":"B4","first-page":"285","article-title":"Hyperuricemia, gout, and cardiovascular disease\u2013an important \u201cmuddle\u201d","volume":"67","author":"Keenan","year":"2009","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4078\/jrd.2022.29.3.140","article-title":"The mechanism of the NLRP3 inflammasome activation and pathogenic implication in the pathogenesis of gout","volume":"29","author":"Kim","year":"2022","journal-title":"J Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1137822","DOI":"10.3389\/fimmu.2023.1137822","article-title":"Role of NLRP3 in the pathogenesis and treatment of gout arthritis","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/s2665-9913(20)30221-6","article-title":"Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout","volume":"3","author":"Hansildaar","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e000712","DOI":"10.1136\/rmdopen-2018-000712","article-title":"Gout and the risk of incident atrial fibrillation in older adults: a study of US medicare data","volume":"4","author":"Singh","year":"2018","journal-title":"RMD Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1136\/annrheumdis-2015-208161","article-title":"Risk of incident atrial fibrillation in gout: a cohort study","volume":"75","author":"Kim","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.numecd.2014.03.012","article-title":"Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan","volume":"24","author":"Chuang","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/14779072.2018.1490644","article-title":"Atrial fibrillation in young patients","volume":"16","author":"Gourraud","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"976976","DOI":"10.1155\/2013\/976976","article-title":"Comparison of atrial fibrillation in the young versus that in the elderly: a review","volume":"2013","author":"Sankaranarayanan","year":"2013","journal-title":"Cardiol Res Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/europace\/euy028","article-title":"Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillation","volume":"20","author":"De With","year":"2018","journal-title":"Europace"},{"key":"B15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tcm.2018.06.004","article-title":"Gout and arrhythmias: in search for causation beyond association","volume":"29","author":"Giannopoulos","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/rheumatology\/kev418","article-title":"Impact of gout on the risk of atrial fibrillation","volume":"55","author":"Kuo","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biomedicines11010059","article-title":"Atrial fibrillation risk and urate-lowering therapy in patients with gout: a cohort study using a clinical database","volume":"11","author":"Liu","year":"2022","journal-title":"Biomedicines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"641136","DOI":"10.3389\/fcvm.2021.641136","article-title":"The key role of uric acid in oxidative stress, inflammation, fibrosis, apoptosis, and immunity in the pathogenesis of atrial fibrillation","volume":"8","author":"Deng","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B19","first-page":"209","article-title":"Uric acid elevation in atrial fibrillation","volume":"51","author":"Letsas","year":"2010","journal-title":"Hellenic J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.hrthm.2014.04.003","article-title":"Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis","volume":"11","author":"Tamariz","year":"2014","journal-title":"Heart Rhythm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.hrthm.2017.07.028","article-title":"Association between oxidative stress and atrial fibrillation","volume":"14","author":"Samman Tahhan","year":"2017","journal-title":"Heart Rhythm"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/eurheartj\/ehv486","article-title":"The role of obesity in atrial fibrillation","volume":"37","author":"Nalliah","year":"2016","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jjcc.2015.04.002","article-title":"Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links","volume":"66","author":"Goudis","year":"2015","journal-title":"J Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/14779072.2019.1581064","article-title":"Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management","volume":"17","author":"Pouwels","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/cvr\/cvaa258","article-title":"Pathophysiology of atrial fibrillation and chronic kidney disease","volume":"117","author":"Ding","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3389\/fphys.2018.01726","article-title":"Chronic kidney disease increases atrial fibrillation inducibility: involvement of inflammation, atrial fibrosis, and connexins","volume":"9","author":"Qiu","year":"2018","journal-title":"Front Physiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0266046","DOI":"10.1371\/journal.pone.0266046","article-title":"Chronic kidney disease and atrial fibrillation: a dangerous combination","volume":"17","author":"Ocak","year":"2022","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e009483","DOI":"10.1161\/circep.120.009483","article-title":"Serum myeloperoxidase, uric acid, and the risk of atrial fibrillation in chronic kidney disease","volume":"14","author":"Correa","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4078\/jrd.2018.25.1.19","article-title":"Interrelationship of uric acid, gout, and metabolic syndrome: focus on hypertension, cardiovascular disease, and insulin resistance","volume":"25","author":"Kim","year":"2018","journal-title":"J Rheum Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1751-7176.2012.00674.x","article-title":"Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort","volume":"14","author":"McAdams-DeMarco","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"101437","DOI":"10.1016\/j.cpcardiol.2022.101437","article-title":"The burden of cardiac arrhythmias in gout: a national representative database study","volume":"48","author":"Mhanna","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease","volume":"135","author":"Robinson","year":"2022","journal-title":"Am J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.3390\/nu11122955","article-title":"Dietary interventions for gout and effect on cardiovascular risk factors: a systematic review","volume":"11","author":"Vedder","year":"2019","journal-title":"Nutrients"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e13048","DOI":"10.1111\/ijcp.13048","article-title":"Uric acid and cardiovascular risk: what genes can say","volume":"72","author":"Kei","year":"2018","journal-title":"Int J Clin Pract"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1862887\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:46:54Z","timestamp":1783403214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1862887\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2026.1862887"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1862887","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"article-number":"1862887"}}